ATA102392A - Topisches terbinafinpräparat und verfahren zu seiner herstellung - Google Patents

Topisches terbinafinpräparat und verfahren zu seiner herstellung

Info

Publication number
ATA102392A
ATA102392A AT0102392A AT102392A ATA102392A AT A102392 A ATA102392 A AT A102392A AT 0102392 A AT0102392 A AT 0102392A AT 102392 A AT102392 A AT 102392A AT A102392 A ATA102392 A AT A102392A
Authority
AT
Austria
Prior art keywords
terbinine
topical
preparation
production
topical terbinine
Prior art date
Application number
AT0102392A
Other languages
English (en)
Other versions
AT400517B (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26298929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATA102392(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB919110884A external-priority patent/GB9110884D0/en
Priority claimed from GB919111477A external-priority patent/GB9111477D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA102392A publication Critical patent/ATA102392A/de
Application granted granted Critical
Publication of AT400517B publication Critical patent/AT400517B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Lubricants (AREA)
  • Cosmetics (AREA)
AT0102392A 1991-05-20 1992-05-19 Topisches terbinafinpräparat und verfahren zu seiner herstellung AT400517B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919110884A GB9110884D0 (en) 1991-05-20 1991-05-20 Pharmaceutical compositions
GB919111477A GB9111477D0 (en) 1991-05-29 1991-05-29 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
ATA102392A true ATA102392A (de) 1995-06-15
AT400517B AT400517B (de) 1996-01-25

Family

ID=26298929

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0102392A AT400517B (de) 1991-05-20 1992-05-19 Topisches terbinafinpräparat und verfahren zu seiner herstellung

Country Status (29)

Country Link
US (2) US5681849A (de)
EP (1) EP0515310B1 (de)
JP (1) JP2651311B2 (de)
KR (1) KR100303095B1 (de)
AT (1) AT400517B (de)
AU (1) AU647922B2 (de)
CA (1) CA2068957C (de)
CH (1) CH683823A5 (de)
CY (1) CY1942A (de)
CZ (2) CZ285275B6 (de)
DE (1) DE4215450B4 (de)
DK (1) DK0515310T3 (de)
ES (1) ES2186668T3 (de)
FI (2) FI102458B1 (de)
FR (1) FR2676646B1 (de)
GB (1) GB2255908B (de)
HK (1) HK148896A (de)
HU (1) HU223343B1 (de)
IE (1) IE70913B1 (de)
IL (1) IL101903A (de)
IT (1) IT1260710B (de)
LU (1) LU88114A1 (de)
MX (1) MX9202328A (de)
NO (1) NO180772C (de)
PT (1) PT515310E (de)
RO (1) RO111986B1 (de)
SA (1) SA92130087B1 (de)
SK (1) SK281615B6 (de)
UA (1) UA39853C2 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
CA2309633C (en) * 1998-10-23 2010-12-14 Idea Innovative Dermale Applikationen Gmbh Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
DE69901377T2 (de) 1999-01-27 2003-01-02 Idea Ag Nichtinvasive Impfung durch die Haut
EP1031347B1 (de) 1999-01-27 2002-04-17 Idea Ag Transnasaler Transport bzw. Impfung mit hochadaptierbaren Trägern
WO2001001962A1 (en) * 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
GB0001928D0 (en) * 2000-01-27 2000-03-22 Novartis Ag Organic compounds
GB0003932D0 (en) 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
US8257688B2 (en) * 2000-03-27 2012-09-04 Taro Pharmaceuticals Industries Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
US7074392B1 (en) * 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
KR100389671B1 (ko) * 2000-11-24 2003-06-27 한미약품 주식회사 염산 테르비나핀을 함유하는 항진균제 외용 약제 조성물
US6490390B1 (en) * 2001-01-05 2002-12-03 Phaethon Communications Grating writing systems based on an acousto-optic element
GB0103046D0 (en) 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
KR100423666B1 (ko) 2001-02-07 2004-03-18 보령제약 주식회사 항진균 외용 제제
GB0108082D0 (en) * 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
BRPI0101486B1 (pt) * 2001-04-17 2017-09-19 Cristália Produtos Químicos Farmacêuticos Ltda. Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
WO2007014130A2 (en) * 2005-07-21 2007-02-01 Nomir Medical Technologies, Inc. Near infrared microbial elimination laser system (nimels)
US20040105881A1 (en) * 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
WO2005000241A2 (en) * 2003-06-23 2005-01-06 Macrochem Corporation Compositons and methods for topical administration
JP5435836B2 (ja) * 2003-07-03 2014-03-05 大正製薬株式会社 外用抗真菌剤組成物
KR100581169B1 (ko) * 2003-07-07 2006-05-17 한국유나이티드제약 주식회사 용해도가 개선된 테르비나핀의 약제조성물 및 그 제조방법
JP2005104916A (ja) * 2003-09-30 2005-04-21 Kobayashi Pharmaceut Co Ltd 抗真菌組成物
US7112561B2 (en) 2003-12-08 2006-09-26 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
US7854943B2 (en) * 2004-06-24 2010-12-21 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
BRPI0512841A (pt) * 2004-07-02 2008-01-08 Warner Lambert Co composições e métodos para o tratamento de infecções patológicas
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
CA2584475A1 (en) * 2004-11-12 2006-05-18 Idea Ag Extended surface aggregates in the treatment of skin conditions
WO2006103638A2 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Topical pharmaceutical compositions of terbinafine and processes for their preparation
US7359057B2 (en) * 2005-08-26 2008-04-15 Ball Aerospace & Technologies Corp. Method and apparatus for measuring small shifts in optical wavelengths
US10525003B2 (en) 2005-09-29 2020-01-07 GSK Consumer Healthcare S.A. Antifungal composition
WO2008073863A2 (en) * 2006-12-08 2008-06-19 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted allylamines
US20100168233A1 (en) * 2007-02-21 2010-07-01 Power Paper Ltd Terbinafine formulation
WO2008105038A1 (ja) * 2007-02-23 2008-09-04 Nichiban Company Limited 抗真菌症用貼付剤
WO2008121709A1 (en) * 2007-03-30 2008-10-09 Transport Pharmaceuticals, Inc. Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug
US20090082469A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched terbinafine
AU2009310437A1 (en) * 2008-10-31 2010-05-06 Moberg Derma Ab Topical composition comprising a combination of at least two penetration enhancing agents
ES2598753T3 (es) 2012-11-27 2017-01-30 Eduardo Cos Alfonso Composición farmacéutica para el tratamiento de la tendinitis calcificada y/o bursitis calcificada
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
CA3006962A1 (en) 2014-12-01 2016-06-09 Achelios Therapeutics Inc. Methods and compositions for treating migraine and conditions associated with pain
GB201511799D0 (en) * 2015-07-06 2015-08-19 Blueberry Therapeutics Ltd Composition and methods of treatment
CA3045004A1 (en) * 2015-12-16 2017-06-22 Achelios Therapeutics, Inc. Methods and compositions for treating peripheral neuropathy
TWI656883B (zh) * 2017-08-21 2019-04-21 高雄醫學大學 光敏劑或其前驅藥物的醫藥載體
WO2023225373A1 (en) * 2022-05-20 2023-11-23 Dermbiont, Inc. Compositions and formulations for use of a pk inhibitor for the prevention, treatment, and improvement of skin diseases, conditions, and disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
DE2716943C2 (de) * 1976-04-28 1986-08-14 Sandoz-Patent-GmbH, 7850 Lörrach N-(3-Phenyl-2-propenyl)-N-(1-naphthylmethyl)-amine, ihre Verwendung und Herstellung
DE3069633D1 (en) * 1979-08-22 1984-12-20 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
FR2572933B1 (fr) * 1981-04-06 1988-03-18 Sandoz Sa Compositions pharmaceutiques topiques a base de tizanidine
JPS6058914A (ja) * 1983-09-12 1985-04-05 Shionogi & Co Ltd イミダゾ−ル系抗真菌性外用ゲル製剤
US4912124A (en) * 1984-02-23 1990-03-27 Ortho Pharmaceutical Corporation Antifungal dermatological solution
JPS61151117A (ja) * 1984-12-25 1986-07-09 Bayer Yakuhin Kk 抗真菌ゲル製剤
US4760096A (en) * 1985-09-27 1988-07-26 Schering Corporation Moisturizing skin preparation
JP2633555B2 (ja) * 1987-03-23 1997-07-23 株式会社東芝 半導体装置の製造方法
EP0325949B1 (de) * 1988-01-13 1991-12-18 Schwarz Pharma Ag Konzentrierte Corticosteroide enthaltende Lösungen und Verfahren zu deren Herstellung
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
US5116603A (en) * 1989-01-31 1992-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oral antifungal preventative, and method of use
HUT58201A (en) * 1989-03-03 1992-02-28 Sandoz Ag Process for producing antiphlogistic pharmaceutical composition containing naphtalene-methan-amino derivatives
FR2646603B1 (fr) * 1989-05-03 1991-07-12 Oreal Composition nettoyante
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
FR2666962B1 (fr) * 1990-09-26 1996-06-14 Oreal Composition antifongique sous forme de spray sec.
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására

Also Published As

Publication number Publication date
FI981777A (fi) 1998-08-18
HU223343B1 (hu) 2004-06-28
IL101903A (en) 1998-08-16
HK148896A (en) 1996-08-16
GB9210579D0 (en) 1992-07-01
US5681849A (en) 1997-10-28
ES2186668T3 (es) 2003-05-16
FI922252A (fi) 1992-11-21
ITRM920361A1 (it) 1993-11-12
NO180772B (no) 1997-03-10
FI102458B (fi) 1998-12-15
CS149192A3 (en) 1992-12-16
EP0515310A1 (de) 1992-11-25
HU9201518D0 (en) 1992-07-28
CZ285275B6 (cs) 1999-06-16
SK281615B6 (sk) 2001-05-10
HUT62466A (en) 1993-05-28
IE921599A1 (en) 1992-12-02
DK0515310T3 (da) 2003-03-03
GB2255908A (en) 1992-11-25
SA92130087B1 (ar) 2006-05-23
NO921958D0 (no) 1992-05-18
FI981777A0 (fi) 1998-08-18
JP2651311B2 (ja) 1997-09-10
EP0515310B1 (de) 2002-11-06
CY1942A (en) 1997-05-16
CA2068957A1 (en) 1992-11-21
FI102458B1 (fi) 1998-12-15
DE4215450B4 (de) 2006-04-27
AU647922B2 (en) 1994-03-31
IE70913B1 (en) 1997-01-15
IL101903A0 (en) 1992-12-30
US5856355A (en) 1999-01-05
UA39853C2 (uk) 2001-07-16
IT1260710B (it) 1996-04-22
RO111986B1 (ro) 1997-04-30
KR920021139A (ko) 1992-12-18
DE4215450A1 (de) 1992-11-26
CZ283019B6 (cs) 1997-12-17
LU88114A1 (fr) 1993-12-06
GB2255908B (en) 1995-10-04
ITRM920361A0 (it) 1992-05-12
AU1631792A (en) 1992-11-26
CH683823A5 (de) 1994-05-31
AT400517B (de) 1996-01-25
NO180772C (no) 1997-06-18
PT515310E (pt) 2003-03-31
JPH05132419A (ja) 1993-05-28
KR100303095B1 (ko) 2001-11-22
NO921958L (no) 1992-11-23
CA2068957C (en) 2002-12-17
MX9202328A (es) 1994-04-29
FR2676646B1 (fr) 1995-05-05
FI922252A0 (fi) 1992-05-18
FR2676646A1 (fr) 1992-11-27

Similar Documents

Publication Publication Date Title
ATA102392A (de) Topisches terbinafinpräparat und verfahren zu seiner herstellung
DE69214306D1 (de) Organopentasiloxan und Verfahren zu seiner Herstellung
DE69211697D1 (de) Antischmelzsicherungsstruktur und verfahren zu ihrer herstellung
DE69221217D1 (de) Verbundfilm und Verfahren zu seiner Herstellung
DE69129746D1 (de) Modifiziertes Polysilazan und Verfahren zu seiner Herstellung
ATA902992A (de) Antigeschwulstmittel und verfahren zu ihrer herstellung
DE69530312D1 (de) Stabiles lycopin konzentrat und verfahren zu seiner herstellung
DE69225439D1 (de) Verdichter und Verfahren zu seiner Herstellung
DE69208372D1 (de) Thermochromes pigment und verfahren zu seiner herstellung
DE69216692D1 (de) Kondensator und Verfahren zu seiner Herstellung
ATE220666T1 (de) 4-diphenylmethylpiperidine und verfahren zu ihrer herstellung
DE59209470D1 (de) Halbleiterbauelement und Verfahren zu seiner Herstellung
DE69301771D1 (de) T-Butyl-R-(-)-4-cyano-3-hydroxybutyrat und Verfahren zu seiner Herstellung
DE69208317D1 (de) Oxidischer supraleiter und verfahren zu seiner herstellung
ATA22489A (de) Geschirrspülmittel und verfahren zu seiner herstellung
ATA60190A (de) Sandwichbauteil und verfahren zu seiner herstellung
DE69523571D1 (de) Pyridylimidazol-derivate und verfahren zu ihrer herstellung
DE69329620D1 (de) Verbindervorrichtung und verfahren zu seiner herstellung
DE69527445D1 (de) Aminooligosaccharid-derivate und verfahren zu ihrer herstellung
DE58905085D1 (de) Copolymerisat aus alpha-methylstyrol und acrylnitril und verfahren zu seiner herstellung.
ATA257387A (de) Antibiotikum a42125 und verfahren zu seiner herstellung
DE69212166D1 (de) Zündspulenanordnung und verfahren zu seiner herstellung
DE69328751D1 (de) Emitter-geschalteter Thyristor und Verfahren zu seiner Herstellung
AT399879B (de) Dihydro-pyrimido-thiazin-derivate und verfahren zu ihrer herstellung
DE59304145D1 (de) Gleitelement und verfahren zu seiner herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
MK07 Expiry

Effective date: 20120519